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Background: Genome-wide association studies (GWAS) have recently identified several new genetic variants
associated with obesity. The majority of the variants are within introns or between genes, suggesting they affect
gene expression, although it is not clear which of the nearby genes they affect. Understanding the regulation of
these genes will be key to determining the role of these variants in the development of obesity and will provide
support for a role of these genes in the development of obesity.
Methods: We examined the expression of 19 GWAS obesity genes in the brain and specifically the hypothalamus,
adipose tissue and liver of mice by real-time quantitative PCR. To determine whether these genes are nutritionally
regulated, as may be expected for genes affecting obesity, we compared tissues from fasting and non-fasting
animals and tissues from mice consuming a high fat high sucrose diet in comparison to standard rodent chow.
Results: We found complex, tissue-dependent patterns of nutritional regulation of most of these genes. For
example, Bat2 expression was increased ~10-fold in the brain of fed mice but was lower or unchanged in the
hypothalamus and adipose tissue. Kctd15 expression was upregulated in the hypothalamus, brain and adipose
tissue of fed mice and downregulated by high fat feeding in liver, adipose tissue and the hypothalamus but not
the remainder of the brain. Sh2b1 expression in the brain and Faim2 expression in adipose tissue were specifically
increased >20-fold in fed mice. Tmem18 expression in adipose tissue but not the brain was reduced 80% by high
fat feeding. Few changes in the expression of these genes were observed in liver.
Conclusions: These data show nutritional regulation of nearly all these GWAS obesity genes, particularly in the
brain and adipose tissue, and provide support for their role in the development of obesity. The complex patterns of
nutritional and tissue-dependent regulation also highlight the difficulty that may be encountered in determining
how the GWAS genetic variants affect gene expression and consequent obesity risk in humans where access to
tissues is constrained.
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Advances in our understanding of the genetic contribu-
tion to obesity have come from recent genome wide
association studies (GWAS). GWAS have identified
several new genetic variants associated with obesity
and its related traits such as body mass index (BMI).
Most prominent amongst these are SNPs within FTO,
which have the strongest effects on obesity risk [1-5].
Additional studies, including large scale meta-analyses,
discovered additional variants associated with obesity-
related traits that have now been replicated [5-7].
These include SNPs within or near MC4R, CTNNBL1,
NPC1, MAF, PTER, PRL, SH2B1, NEGR1, the SEC16B-
RASAL2 region, TMEM18, the SFRS10-ETV5-DGKG
region, BDNF, FAIM2, KCTD15, the NCR3-AIF1-BAT2
region, GNPDA2, and MTCH2 [8-11].
Alterations in a few of these genes have previously
been shown to affect body weight [12-16]. Melanocortin
4 receptor, MC4R, mutations are the most common
cause of monogenic severe obesity and missense variants
within the gene have been associated with altered risk
for common obesity [16,17]. Brain derived neurotrophic
factor, BDNF, regulates feeding, its expression is altered
by consumption of high fat diet, and variants within the
gene have previously been associated with obesity
[13,14,16,18]. Sh2b1 knockouts are obese, and this gene
is known to play important roles in leptin signalling
[15,19]. Understanding the site of action and function of
these new obesity genes may provide valuable insight
into the pathogenesis of obesity. However, despite the
extensive investments in GWAS studies, to date studies
of the biology of these genes have been limited. Little is
known about most of these GWAS obesity genes and
their role in the regulation of body weight is unknown.
A better understanding of these genes is needed to
capitalize on the information generated by the GWAS.
The SNPs identified by the GWAS generally do not
affect the amino acid sequence of the mature protein.
They are typically intronic or intergenic. The location of
these SNPs suggests they likely affect the regulation of
the gene they are located within or of nearby genes, and
in some cases it is not clear which of the nearby genes
they may be affecting [7,8,11,20]. Regulation of a gene
may also be tissue specific, or occur in response to cer-
tain physiological states. Many genes involved in the
regulation of energy homeostasis are metabolically regu-
lated [21-24]. Expression of FTO was shown to be regu-
lated by feeding and fasting in the hypothalamus [25].
Thus we hypothesize that if these GWAS genes affect
the development of obesity they may be nutritionally
regulated.
Knowledge of the regulation of the GWAS obesity
genes is critical for understanding how the associated
SNPs alter the function of their cognate genes and thushow these genes may affect the development of obesity.
This requires knowledge of the tissues where the gene is
normally expressed and an understanding of the physio-
logical processes that regulate it. We sought to deter-
mine whether metabolic factors affect the regulation of
the newly discovered obesity genes. We examined the
regulation of these genes by feeding/fasting status and
by the consumption of a diet high in fat and sugar. Here
we show that most of the recently identified obesity
genes are regulated by dietary status, providing support
for their role in processes relevant to the development
of obesity. These patterns of regulation were often
tissue-dependent and largely unique for each gene, sug-
gesting that many of these genes affect distinct pathways
in the development of obesity and that analysis of the
effects of the GWAS SNPs on gene expression may need
to be performed in all physiologically relevant tissues
and under multiple physiological contexts.
Methods
Animals
Animals were housed in an environmentally controlled
facility with 14 hour light cycles (7 am – 9 pm). Female
C57BL/6 J mice were given free access to water and ei-
ther a standard rodent chow (LabDiet 5010, PMI Nutri-
tion, St. Louis MO, USA) or a diet containing 60%
calories from fat (primarily lard) and 20% calories from
sugar (sucrose and maltodextrin; D12492, Research
Diets, New Brunswick NJ, USA) from weaning. This
high fat diet has a cholesterol content of 300.8 mg/kg
from the lard. The mice were sacrificed by CO2 asphyxi-
ation at 8 weeks of age. Tissues were rapidly dissected
and immediately placed in liquid nitrogen then stored at
−80°C. Prior to sacrifice, animals were either fasted 4
hours (9 am – 1 pm) or dissections were performed at
9 am without prior removal of food (“fed”). All proce-
dures were approved by the UBC Committee on Animal
Care and were performed according to Canadian Coun-
cil on Animal Care guidelines.
RNA extraction and cDNA synthesis
Prior to extraction, tissue samples were cut into small
pieces and placed in RNA Later Ice (Applied Biosystems,
Carlsbad CA, USA) at −20°C for at least 24 hrs. RNA was
extracted using a commercially available kit (E.Z.N.A.™
Total RNA II, Omega Biotek, Norcross GA, USA). The
integrity of the RNA was verified by performing formal-
dehyde denaturing agarose gel electrophoresis for all
samples except the hypothalamus, for which too little
RNA was obtained. Following DNAse I digestion (Fer-
mentas, Burlington ON, Canada) to remove any contam-
inating genomic DNA, cDNA synthesis (RevertAid First
Strand cDNA Synthesis Kit, Fermentas, Burlington ON,
Canada) was performed using 1 μg of RNA with mixed
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3.6 ng/μL random hexamer final concentration) accord-
ing to the manufacturer’s directions. RNA was subse-
quently removed with RNase H digestion (Fermentas,
Burlington ON, Canada). Successful cDNA synthesis was
verified by PCR amplification of our control genes and
visualization of a band of the appropriate size on an agar-
ose gel.
Gene expression
We examined the dietary regulation of Aif1, Bat2,
C10orf97, Ctnnbl1, Dgkg, Etv5, Faim2, Gnpda2, Kctd15,
Maf, Mtch2, Negr1, Npc1, Pter, Rasal2, Sec16b, Sfrs10,
Sh2b1, and Tmem18. Primer sequences are provided in
Additional file 1 Table S1. When there were possible al-
ternatively spliced forms identified in the UCSC genome
browser (www.genome.ucsc.edu), we designed the pri-
mers in regions common to all isoforms. All primer
pairs spanned an intron. Ncr3 is a pseudogene in mice.
It does not encode a functional protein due to the pres-
ence of premature stop codons [26] and was not exam-
ined in our studies.
Relative gene expression was measured using a Ste-
pOne Plus real time thermocycler (Applied Biosystems
Inc., Carlsbad CA, USA), using SYBR green I for detec-
tion (PerfeCTa SYBR Green FastMix, VWR Inter-
national, Edmonton AB, Canada). Forty cycles of
amplification were performed followed by melt-curve
analysis for verification that only a single product was
amplified from each sample. This verification was also
performed by direct visualization of PCR amplification
products on an agarose gel. Baseline correction, thresh-
old setting, and calculation of the Ct value were per-
formed automatically by the StepOne software (version
2.1, Applied Biosystems, Carlsbad CA, USA).
Cyclophilin (Ppib) was chosen as the reference gene,
as it proved most robust to changes in expression by ex-
perimental condition across each of the tissues in com-
parison to beta-actin (Actb), Gapdh, and Arbp. This
control gene was included on several plates contempor-
aneous with the genes being assessed, and for each sam-
ple the average value of this gene across its multiple
replicates was used for normalization of that sample.
Delta Ct (ΔCt) values were calculated by subtracting the
cycle threshold (Ct) value for each gene from this aver-
age value. Delta delta Ct (ΔΔCt) values were calculated
for each sample by subtracting its ΔCt value from the
average ΔCt for the chow-fed, fasted controls in the
same experiment. Initially, single measurements were
made for each sample (n = 5 per dietary group). When
there was a potential difference between groups, repli-
cate experiments were performed, including additional
samples (up to 10 animals per group). The numbers vary
for each tissue and gene because of poor-quality or lowyields of RNA obtained from some samples and the
number of samples with sufficient RNA available at the
time for analysis. For each sample, the average ΔΔCt of
all its replicates across experiments was used for statis-
tical analysis.
Statistical analysis
Our study was comprised of three groups: chow-fed
mice fasted prior to tissue collection (controls); chow-
fed mice not fasted prior to tissue collection, “fed”; and
high fat diet-fed mice that were fasted prior to tissue
collection. The average ΔΔCt values of the high fat-fed
and fed groups were compared to that of the fasted
chow-fed control group and the significance of each
assessed by a non-parametric Mann–Whitney U test be-
cause of the small sample size. Because this results in
two comparisons for each gene (chow-fed, fasted vs.
non-fasted mice; fasted chow-fed vs. fasted high fat diet-
fed mice), the resulting P-values were subsequently Bon-
ferroni corrected by multiplying them by 2. This
approach was chosen over a Kruskal-Wallis test because
the comparison between chow-fed “fed” mice and fasted
high fat diet-fed mice that is accounted for in the
Kruskal-Wallis test is not meaningful. The average
fold change for each group shown in the figures was
calculated as 2-average ΔΔCt, with the error bars as
2-average ΔΔCt ± its SE [27].
Results
Regulation of GWAS obesity genes by dietary status in
hypothalamus
All 19 of the GWAS genes we examined were expressed
in the hypothalamus. Many were regulated by either
feeding/fasting or by consumption of the high fat diet
(Figure 1), but only two genes, Kctd15 and likely Mtch2,
were regulated by both conditions. The expression of
many genes was increased in non-fasted animals. Kctd15
expression was increased 2.1-fold in fed animals,
C10orf97 expression was increased 2.3-fold, and expres-
sion of Sfrs10 was also increased an average of 2.2-fold.
The expression of Pter was increased 1.6-fold, and we
detected a 1.8-fold increase in Gnpda2 expression. In
addition, Ctnnbl1 expression was increased an average
of 1.5-fold, although this did not reach statistical signifi-
cance. Similarly, the expression of Mtch2, Faim2 and
Dgkg were also increased in the fed mice compared to
fasted, however due to the large variability in expression
levels, these were not significant.
In contrast to the small differences in gene expression
observed in fed compared to fasted animals, chronic
feeding of a high fat diet resulted in substantial changes
in expression (Figure 1). Kctd15 was decreased a marked
20-fold in animals consuming a high fat diet (i.e. expres-
sion was ~5% of that seen in chow-fed, fasted control
Figure 1 Regulation of GWAS obesity genes in the hypothalamus in the fed state and by high fat feeding. Open bars represent the
chow-fed, fasted controls; red bars represent the chow-fed non-fasted group; and blue bars represent the high fat fed group (fasted prior to
tissue collection). The number of mice in the chow fasted, chow fed, and HFD fasted groups were: Bat2 (10, 5, 7), C10orf97 (10, 7, 5), Dgkg
(4, 5, 5), Etv5 (10, 7, 7) Faim2 (4, 5, 5), Gnpda2 (9, 9, 6), Kctd15 (7, 5, 6), Maf (7, 7, 7), Mtch2 (10, 9, 7), Negr1 (10, 7, 7), Npc1 (10, 5, 7), Pter (10, 8, 6),
Sfrs10 (10, 7, 5) and Sh2b1 (9, 6, 7), respectively. P-values vs. the chow-fed fasted controls: * <0.05, ** <0.01, # <0.1.
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~10-fold in animals fed the high fat diet. Npc1 gene ex-
pression was decreased by ~4-fold. Maf expression was
~3-fold lower, but due to the high variability in the con-
trol group did not quite statistical significance after Bon-
ferroni correction. Expression of Etv5 and Negr1 was
only 15% and 19%, respectively, of that observed in con-
trols, although neither reached statistical significance.
Mtch2 was the only gene that had increased expression
with high fat feeding in the hypothalamus. We did not
observe any significant changes in hypothalamic gene
expression with feeding or consumption of a high fat
diet for Aif1, Dgkg, Faim2, Rasal2, Sec16b or Tmem18
(not shown).
Regulation of GWAS genes by dietary status in whole
brain excluding hypothalamus
Many regions of the brain outside the hypothalamus are
also important for the regulation of food intake and en-
ergy balance [28]. We detected expression of all 19 genes
in these other regions of the brain. Similar to the hypo-
thalamus, the expression of many genes differed between
the fasted and fed groups (Figure 2). In contrast to theFigure 2 Regulation of GWAS obesity genes in the remainder of the b
the chow-fed, fasted controls; red bars represent the chow-fed non-fasted
tissue collection). The number of mice in the chow fasted, chow fed, and H
Kctd15 (5, 10, 5), Maf (7, 10, 7), Negr1 (7, 10, 5), Npc1 (7, 10, 5), Rasal2 (7, 10,
respectively. *P <0.05 vs. the chow-fed fasted controls.hypothalamus, however, the changes in expression were
often much larger and occurred primarily in non-fasted
animals. Most notably, expression of Kctd15 and Sh2b1
were increased >20-fold, and expression levels of Bat2,
Etv5, Negr1and Tmem18 were increased ~10-fold in the
fed group. Changes in Kctd15 expression likely did not
reach statistical significance due to a large variability in
the increase in expression. While the magnitude was
variable, most samples had at least 15-fold increased
Kctd15 expression. Feeding was also associated with a 2
to 4 fold increase in the expression of Sec16b, Rasal2,
and Npc1. We observed similar trends in the expression
of Maf that did not reach statistical significance.
In marked contrast to what was observed in the hypo-
thalamus where several genes were substantially downre-
gulated by high fat feeding, the expression of only a
single gene in the remainder of the brain was altered by
high fat feeding. Expression of Faim2 was reduced ~50%
in the high fat-fed group compared to the chow-fed mice
(Figure 2). We did not observe any differences in the ex-
pression of Aif1, Mtch2, Dgkg, Sfrs10, Pter, Ctnnbl1,
Gnpda2 or C10orf97 under any condition in the remain-
der of the brain (not shown).rain in the fed state and by high fat feeding. Open bars represent
group; and blue bars represent the high fat fed group (fasted prior to
FD fasted groups were: Bat2 (7, 10, 5), Etv5 (7, 10, 7) Faim2 (7, 10, 7),
6), Sec16b (7, 10, 5), Sh2b1 (7, 10, 7), and Tmem18 (7, 10, 5),
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tissue
All the GWAS genes we assessed were also expressed in
white adipose tissue. Several GWAS obesity genes were
highly differentially regulated in adipose tissue from high
fat-fed compared to chow-fed mice. Many genes had
reduced expression in high fat diet-fed mice (Figure 3).
Most strikingly, we observed a ~10-fold reduction in ex-
pression of Negr1 in the high fat-fed mice compared to
the chow-fed controls. Etv5 and Kctd15 were also mark-
edly downregulated in mice consuming the high fat diet
(~8-fold and 5-fold, respectively). Decreased expression
of Maf, Npc1, Rasal2, Sec16b, Sh2b1, and Tmem18 in
high fat diet-fed mice ranged from ~2.5-fold for Npc1
to 6-fold for Rasal2. We observed a similar decrease in
Bat2 expression with high fat feeding (3-fold), although
this did not reach statistical significance. In contrast,
Aif1 had a small but significant increase in gene expres-
sion in adipose tissue of the mice fed a high fat diet
(2.1-fold).
We found the expression of three genes changed sig-
nificantly by feeding status in adipose tissue. Faim2 was
upregulated a remarkable 20-fold in fed versus fasted
mice consuming normal chow (Figure 3). Expression of
Mtch2 was increased an average of 8-fold and Kctd15
was increased ~5-fold in fed animals. A similar trend
was observed for Etv5, which had 4-fold higher expres-
sion in adipose tissue of fed mice. Smaller increases
were observed for Dgkg and Negr1 (3.5 and 2.3-fold, re-
spectively), but these were not significant. We did not
detect any significant differences in gene expression for
Dgkg, Ctnnbl1, Sfrs10, Bat2, Pter, Gnpda2, or C10orf97
in either group.Regulation by dietary status in liver
Of the 19 genes we assessed, all except Faim2 and Negr1
were expressed in the liver. In contrast to the tissues
above, we observed few differences in gene expression inFigure 3 Regulation of GWAS obesity genes in adipose tissue in the f
chow-fed, fasted controls; red bars represent the chow-fed non-fasted grou
tissue collection). The number of mice in the chow fasted, chow fed, and H
Dgkg (7, 6, 4), Etv5 (7, 4, 8), Faim2 (7, 6, 7), Kctd15 (7, 4, 9), Maf (7, 7, 9), Mtch
Sfrs10 (7, 8, 5), Sh2b1 (7, 5, 9), and Tmem18 (7, 6, 9), respectively. P-values vsthe liver (Figure 4). Expression of Kctd15 was decreased
an average of 20-fold in high fat diet-fed mice compared
to chow-fed mice, and was the only gene for which sig-
nificant differences were detected. Sh2b1 expression was
decreased by a similar amount but was not significant
(P = 0.14) likely due to the variability of the controls.
Rasal2 expression was decreased an average 3.4-fold in
the high fat diet-fed mice. Expression of Gnpda2 was
decreased 2-fold in the high fat-fed mice, and by a simi-
lar amount in fed animals compared to fasted. Similarly,
Npc1 expression was decreased an average 2.6-fold in
fed animals compared with fasted. Interestingly, expres-
sion of Dgkg was low but detectable in both groups of
chow-fed mice, whereas expression could not be
detected in five of six high fat diet-fed mice. No differ-
ences were observed in the expression of the other genes
expressed in liver (Sec16b, Maf, Mtch2, Tmem18, Aif1,
Bat2, Sfrs10, Pter, Ctnnbl1, Etv5, and C10orf97) in re-
sponse to fed status or consumption of the high fat diet.Discussion
GWAS have identified many new SNPs associated with
the development of obesity. Most of these SNPs are
located in introns or intergenic regions, suggesting they
affect the regulation of the corresponding gene or
nearby gene(s), but which gene or genes they affect is
unknown. Little is known about most of these genes or
how they may affect the development of obesity, but
understanding their regulation is a key step that may
provide important clues. Many genes involved in metab-
olism and maintaining energy balance are regulated in
response to feeding and fasting or by dietary compo-
nents. Identification of such regulatory patterns would
provide support for a potential role in the development
of obesity. To begin to understand the regulation of the
GWAS obesity genes and if they are nutritionally regu-
lated we examined how changes in dietary conditions
affect their expression.ed state and by high fat feeding. Open bars represent the
p; and blue bars represent the high fat fed group (fasted prior to
FD fasted groups were: Aif1 (7, 8, 9), Bat2 (7, 6, 9), C10orf97 (7, 8, 5),
2 (7, 8, 5), Negr1 (7, 4, 8), Npc1 (7, 8, 9), Rasal2 (7, 7, 9), Sec16b (7, 5, 8),
. the chow-fed fasted controls: * <0.05, ** <0.01, # <0.1.
Figure 4 Regulation of GWAS obesity genes in the liver in the fed state and by high fat feeding. Open bars represent the chow-fed,
fasted controls; red bars represent the chow-fed non-fasted group; and blue bars represent the high fat fed group (fasted prior to tissue
collection). The number of mice in the chow fasted, chow fed, and HFD fasted groups were: Dgkg (5, 4, 6), Etv5 (7, 5, 3), Gnpda2 (7, 5, 6),
Kctd15 (5, 4, 4), Npc1 (7, 5, 5), Rasal2 (7, 5, 6), and Sh2b1 (7, 5, 6), respectively. P-values vs. the chow-fed fasted controls: * <0.05, # <0.1. ND=not
detected.
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most of these new obesity genes. Only one gene, dia-
cylglceryol kinase gamma (Dgkg), did not significantly
change under any condition tested. However, given the
role of this kinase in second messenger signalling, it is
likely that it may not be physiologically regulated at the
level of transcription but rather by activity of the en-
zyme. Note that this does not preclude the possibility
that the GWAS SNPs may affect its basal transcription
levels. The regulation of some genes was highly tissue
specific. Four transcripts, Sfrs10, C10orf97, Pter, and
Ctnnbl1 were increased in hypothalami of fed animals
compared to fasted, but were not changed by this condi-
tion in other regions of the brain, liver or adipose tissue,
or by high fat feeding in any tissue. Thus these genes
may have unique functions in the hypothalamus regulat-
ing energy balance and the development of obesity.
Similarly, Aif1 (allograft inflammatory factor 1) expres-
sion was increased by high fat feeding only in adipose
tissue, whereas no differences in its expression were
observed in the other tissues or in fed animals. It is un-
clear whether this reflects increased inflammation of adi-
pose tissue in the high fat-fed mice (e.g. expression from
increased amounts of inflammatory cells in the tissue),
or whether this suggests that the role of Aif1 in obesity
may be mediated via specific actions in adipose tissue.
In contrast to the above genes whose expression was
affected by a single condition in a single tissue, the ex-
pression of other genes was more complex and altered
in multiple tissues or by both conditions. Gnpda2 ex-
pression was increased in the hypothalamus and
decreased in the liver of fed animals, whereas its expres-
sion did not differ in other regions of the brain or adi-
pose tissue in fed vs. fasted animals. We did not detect
any significant changes of this gene in response to high
fat diet consumption, although another group has re-
cently reported decreased expression of this gene in high
fat diet-fed rats [29]. Several transcripts were decreased
in the hypothalamus by high fat feeding and increased inthe remainder of the brain in the fed state, with variable
patterns in adipose tissue. Kctd15 regulation was the
most consistent across tissues, with its expression being
increased with feeding in hypothalamus, brain and adi-
pose tissue (but not liver) and decreased by high fat diet
consumption in hypothalamus, adipose tissue and liver
(but not brain). A recent study has also found decreased
Kctd15 expression in hypothalamus and adipose tissue
of high fat-fed rats, although they did not observe
reduced expression in liver [29].
We also observed a large range in the magnitude of
the changes in gene expression, and for each transcript
the magnitude of the change in expression was not the
same in each tissue. For example, expression of Kctd15
was increased >20-fold in the brain of fed animals, but
only by 2- to 4-fold in the hypothalamus and adipose tis-
sue. These complex and tissue-dependent patterns of
regulation in response to nutritional status suggest that
these genes have important and perhaps distinct roles in
several tissues.
Although each gene showed distinct patterns and mag-
nitude of regulation across tissues and nutritional condi-
tions, we observed striking consistency in the overall
pattern of regulation by feeding and chronic high fat diet
consumption. With few exceptions (Npc1 and Gnpda2 in
liver, Figure 4), all genes regulated by feeding/fasting
were upregulated in the non-fasted animals. This sug-
gests that most transcripts respond to nutrient intake or
increased nutrient levels, rather than acting as cues initi-
ating food intake or promoting the mobilization of en-
ergy stores. Several transcription factors, co-activators,
and factors affecting chromatin structure are known to
increase expression of target genes in response to
changes in cellular nutrient levels and energy status and
thus may be important for the regulation of these genes
[21-23]. Regulation of gene expression by feeding was
prominent in the hypothalamus and remainder of brain,
and also for some transcripts in adipose tissue. In fact,
changes in response to feeding-fasting status accounted
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the brain; only one gene (Faim2) was regulated by high
fat feeding in the brain. Interestingly, however, there was
little overlap in the genes regulated by feeding between
the hypothalamus and the remainder of the brain, sug-
gesting that distinct nutrient-responsive regulatory path-
ways operate in various regions of the brain. In contrast,
consumption of a high fat diet was associated with a re-
duction in expression of all of the regulated transcripts
with the exception of Mtch2 in hypothalamus and Aif1 in
adipose tissue. High fat diet consumption affected gene
expression mainly in adipose tissue and the hypothal-
amus but not the rest of the brain, suggesting energy
storage and homeostatic regulation of energy balance
may be preferentially affected by today’s obesogenic diets.
This also suggests that high fat diets may predominantly
down-regulate pathways important for normal adipose
tissue function. Previous studies have shown reduced adi-
pogenic gene expression in obese individuals [30-32].
Our findings further suggest that the effects of these
genes on the development of obesity may occur in tissues
in addition to the brain, which was previously suggested
to be their likely site of action [8,11]. Consistent with
this, Negr1 has recently been shown to be expressed in
adipose tissue and to be associated with gene expression
networks [33]. Mtch2 expression in adipose tissue is
increased in obese individuals [34] and has been shown
to be increased in high fat-fed rats [29], although we did
not observe changes in its expression in adipose tissue in
response to high fat feeding (Figure 3). Somewhat sur-
prisingly given its key role in whole-body metabolism
and that high fat diets have previously been shown to
regulate the hepatic expression of many genes [32], very
few of the GWAS obesity genes had altered expression
in the liver, suggesting that the metabolic processes of
the liver may not play a significant role in the mainten-
ance of whole body energy homeostasis. We also found
that most of these genes except Etv5, Mtch2, Pter and
Tmem18 had relatively low to no detectable expression
in soleus muscle (not shown). A recent study examining
the expression of a partially-overlapping subset of
GWAS obesity genes also found modest changes in ex-
pression of only a few genes in liver and muscle [29].
The nutritional regulation of these new obesity genes
provides support for their potential role in the regulation
of energy balance. These data have several important
implications for studies examining the effects of the
GWAS SNPs on gene regulation and ultimately the
mechanisms by which these genes affect the development
of obesity. The highly tissue-dependent patterns of regu-
lation suggest that all tissues where a gene is expressed
will need to be examined to determine whether the par-
ticular SNPs identified by the GWAS affect the expres-
sion of a gene. This is further highlighted by the complexpatterns and variability in magnitude of expression
changes for a transcript in different tissues. Analysis of
the effects of the GWAS SNPs on gene expression in
lymphocytes has been suggested since this is a readily ac-
cessible source of RNA, and differences in lymphocyte
gene expression between lean and obese individuals have
been detected [35]. This may be useful if the SNPs affect
basal transcription of a gene, but will not be useful if the
SNPs affect enhancer elements. Indeed, in a study exam-
ining the effects of diabetes-associated SNPs on gene ex-
pression, many correlations between genotype and
expression were found in muscle and adipose tissue that
were not observed in lymphocytes [36]. Similarly, SNPs
affecting gene expression in lymphocytes were only asso-
ciated with inflammatory and auto-immune diseases not
with metabolic diseases [37]. Thus it may be very difficult
to pinpoint the effects of these obesity GWAS SNPs on
transcript levels. To understand the role of these genes in
the development of obesity it will be necessary to fully
understand the role of each gene in each physiologically
relevant tissue, as they are regulated and thus may be-
have differently depending upon the tissue being
examined.
Transcriptional regulatory elements can be located be-
fore, within, or even following a gene, and can be located
at substantial distance (up to 1 Mb) from the gene [38].
Thus it is possible that the variants detected by the
GWAS studies affect the regulation of other nearby
genes, not just those that are closest to the SNP. We
chose to focus our analyses on the genes reported by the
GWAS studies as the most likely genes affected by the
associated variants. The functions of many of these
genes are not well described, and it is not clear how they
may affect the development of obesity. We performed
these studies to learn more about these genes, determine
whether their expression patterns were consistent with
them having a role in the regulation of body weight, and
examine whether their expression is affected by known
metabolic regulatory factors. While our data provide
support for all the genes having a potential role in the
development of obesity, they do not confirm that these
are “the genes” nor do they exclude the possibility that
the GWAS SNPs affect the regulation of other nearby
genes.
Three of the obesity SNPs identified by Thorliefsson
and colleagues [8] were found in gene dense regions
where the SNP was not clearly more closely related to a
single gene, and were consequently identified as being
within gene clusters: SEC16B-RASAL2, SFRS10-ETV5-
DGKG, and NCR3-AIF1-BAT2. We examined the ex-
pression of the genes in each cluster with the hope of
discovering regulatory patterns that may point to the
more likely causative gene in each cluster. Unfortunately
these studies provide little support favoring one of the
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tissues relevant to the regulation of body weight. For the
first cluster, both Sec16b and Rasal2 were increased in
the fed state in the brain and decreased by high fat feed-
ing in adipose tissue. Neither was altered in the hypo-
thalamus, while Rasal2 expression was also decreased in
response to high fat feeding in the liver. The similar ex-
pression patterns make it difficult to prioritize one over
the other as likely being the causative gene and also sug-
gest that there may in fact be common regulatory ele-
ments affecting multiple genes in the region. The genes
in the second and third clusters showed very different
expression patterns from each other. In the second clus-
ter, Sfrs10 expression was increased in the hypothalamus
in fed mice but did not change in any of the other tis-
sues. Etv5 expression in the hypothalamus was decreased
by high fat feeding and its expression increased in the
brain and adipose tissue of fed animals. Dgkg expression,
although relatively high in the hypothalamus and re-
mainder of the brain, was not affected by fasting or the
consumption of a high fat diet. For the third cluster, dif-
ferential expression of Aif1 was detected in adipose tis-
sue, where it was the only gene to increase in response
to a high fat diet. In contrast, Bat2 expression was
decreased by the high fat diet in hypothalamus,
increased by feeding in brain, and was not changed in
liver or adipose tissue. The expression of the Ncr3
pseudogene was not analyzed. Thus each member of the
last two groups has a differential regulation in response
to changing dietary conditions, which suggests that the
causative variant(s) at these loci may affect just one of
the genes rather than the coordinate regulation of mul-
tiple genes. However, for each cluster all the genes had
potentially relevant changes in expression and it is un-
clear which of the genes is most likely to be affected by
the GWAS SNP based on these analyses.
Recently other studies have reported expression pat-
terns of some of these genes. One of these has shown
that Tmem18 is expressed in most neurons [39]. These
studies found no change in its expression in the hypo-
thalamus or brainstem with prolonged (16 or 24 hour)
fasting, 48 hour sucrose or fat ingestion or in response
to chronic addition of 10% sucrose to the diet compared
to ad-lib chow-fed mice [39]. Consistent with these find-
ings, we saw no evidence of altered Tmem18 expression
in response to chronic consumption of a high fat-
sucrose diet. In contrast, however, we found ~8-fold
higher levels of Tmem18 in the brain of non-fasted ani-
mals (Figure 2). A recent study reproduced our finding
of reduced expression of Etv5 and Sh2b1 in the hypo-
thalamus and Kctd15 in the hypothalamus and adipose
tissue of high fat-fed animals [29]. In contrast, this study
also found decreased expression of Kctd15 and Gnpda2
in the hypothalamus and Tmem18 in the liver,hypothalamus and soleus muscle, and increased expres-
sion of Mtch2 in adipose tissue and Pter in adipose tis-
sue and liver of high fat-fed rats, which we did not
observe [29]. The reasons for these discrepancies may
relate to experimental design, such as differences in the
species and strain studied; the diet used and its duration;
the time of day of sacrifice; and the fasting conditions
used, and require further investigation.
Conclusions
These studies have shown that the regulation of these
new GWAS obesity genes in response to dietary condi-
tions is complex and often tissue-dependent. Knowledge
of the regulation of these genes will help in determining
their role in obesity. These data provide supportive evi-
dence for a role of these genes in the regulation of en-
ergy metabolism, but suggest that discovery of the
mechanism by which the regulatory SNPs identified in
the GWAS affect these genes will require tissue and
context specific analysis.Additional file
Additional file 1: Table S1. Primer sequences used in these studies.
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